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Specific inhibition of Egr-1 prevents mesangial cell hypercellu- ties, also regulate glomerular hemodynamics. Mesangial
larity in experimental nephritis. cells represent approximately 35% to 40% of the total
Background. Mesangial cell proliferation is a frequent find- glomerular cell population [1].ing in glomerulonephritis. In cultured mesangial cells, we dem-
One important reaction pattern of mesangial cells toonstrated that inhibition of the zinc finger transcription factor,
glomerular injury is an increase in proliferation rate andearly growth response gene-1 (Egr-1), by specific antisense
oligonucleotides (AS ODN) blocks mesangial cell prolifera- mesangial cell proliferation is a frequent and characteristic
tion. Therefore, we here investigated the effect of Egr-1 inhibi- finding in many types of glomerular kidney diseases, includ-
tion on the course of an experimental mesangioproliferative
ing membranoproliferative glomerulonephritis (GN), post-glomerulonephritis in vivo.
infectious GN, immunoglobulin A (IgA) nephropathy,Methods. On day 3 after induction of anti-Thy-1.1 nephritis,
specific glomerular oligonucleotide transfer was achieved by Henoch-Schoenlein purpura, lupus nephritis, or diabetic
injection of an oligonucleotide/hemagglutinating virus of Ja- nephropathy. Mesangial cell proliferation often proceeds
pan/liposome mixture into the left renal artery. The right kid- and then maintains or accelerates glomerular matrix de-
ney was left untreated.
position and sclerosis that ultimately lead to loss of renalResults. Induction of nephritis led to a sixfold induction of
function and the need for renal replacement therapyEgr-1 protein on day 6 of disease. This increase in Egr-1 expres-
sion was reduced by 48% in the left kidney by transfer of [2]. One potential strategy to prevent progressive renal
specific AS ODN. In parallel, the increases in glomerular cellu- insufficiency is, therefore, to interfere with early mesan-
larity, number of mitoses, and glomerular tuft area observed gial cell activation and especially mesangial cell prolifer-in day 6 nephritic animals were inhibited in the left kidney by
ation. A factor that we have shown to be intricately60%, 53%, and 50%, respectively. Changes in the right kidney
linked with mesangial cell proliferation is the transcrip-were not significantly influenced. Likewise, control oligonucleo-
tides showed no effect. Finally, the expression of platelet-derived tion factor, early growth response gene-1 (Egr-1) [3, 4].
growth factor-B (PDGF-B), a known target gene of Egr-1, was Egr-1, also known as NFGI-A, Krox 24, TIS 8, or zif
repressed by transfer of specific AS ODN against Egr-1. 268, belongs to the immediate early gene family that alsoConclusion. We conclude that the transcription factor Egr-1
includes the fos and jun families of transcription factors.plays a critical role for mesangial cell proliferation in vivo.
It is rapidly and transiently induced after mitogenic stim-Interfering with the induction of Egr-1 or with its target genes
could give rise to novel therapeutic principles in mesangioproli- ulation [5, 6], but also after differentiation signals [7, 8],
ferative glomerulonephritis. during radiation injury [9], hypoxia [10, 11], depolariza-
tion [7], or after induction of apoptosis [12].
The Egr-1 gene encodes a 75 to 82 kD evolutionarily
Mesangial cells are specialized pericytes that serve conserved nuclear phosphoprotein with a DNA binding
to maintain the delicate architecture of the glomerular domain composed of three zinc fingers. Egr-1 binds spe-
capillary tuft and, by means of their contractile proper- cifically to a 5-GCG(G/T)GGGCG-3 consensus se-
quence and acts as a transcriptional activator [13].
We and others have shown that Egr-1 expression isKey words: antisense, transcription factor, mesangioproliferative glo-
merulonephritis, immediate early gene, liposome. regulated on the transcriptional level by protein kinase
C–dependent and independent mechanisms. InductionReceived for publication March 26, 2002
involves the interaction between serum response factorand in revised form July 18, 2002
Accepted for publication November 14, 2002 (SRF) and ternary complex factor at the serum response
element (SRE) consensus sequences in the Egr-1 pro- 2003 by the International Society of Nephrology
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moter [13–15]. The importance of the SREs for Egr-1 in vitro but also in vivo in a balloon injury model of
induction was also confirmed in SRF-deficient mice [16]. the rat carotid artery wall, where excessive neointima
Several downstream target genes of Egr-1 have been formation was prevented [38]. High-level expression of
identified. These include growth factors like the platelet- Egr-1 and Egr-1–induced genes was also found in mouse
derived growth factor-A (PDGF-A) [17, 18] or PDGF-B and human atherosclerotic lesions, predominantly in
[19], basic fibroblast growth factor (bFGF) [20], trans- SMC and endothelial cells [39].
forming growth factor- (TGF-) [21], thrombospondin-1 Our studies in cultured mesangial cells demonstrated
[22], the adhesion molecules CD44 and intercellular ad- that Egr-1 induction closely correlated with mesangial
hesion molecule-1 (ICAM-1) [23, 24], the cytokines tu- cell proliferation. Specific AS ODN directed against Egr-1
mor-necrosis factor- (TNF-) and monocyte-colony- inhibited Egr-1 expression on the mRNA and protein
stimulating factor (M-CSF), apolipoprotein A1, different level and dose-dependently prevented PDGF, endo-
cell-cycle components like cyclin D1, p53, Rad, Gi2, thelin-1 or serum-induced mesangial cell proliferation in
and guanylate cyclase1 [19, 25, 26], luteinizing hormone vitro [3, 4]. Several AS ODN were tested and their ability
(LH)- [27, 28], and components of the coagulation sys- to block Egr-1 induction closely correlated with their
tem like plasminogen activator or tissue factor (TF) [29]. potential to block mesangial cell proliferation. Control
When investigating the functional consequences of ODN were without detectable effects. Furthermore, we
Egr-1 deficiency, Lee et al [27, 28] noted that, in embry- found that nitric oxide application induced inhibition of
onic stem cells with an inactivated Egr-1 gene, growth mesangial cell proliferation by interfering with binding
and differentiation proceed normally. Similarly, Egr-1– of Egr-1 to its DNA recognition sequence [40]. In the
deficient mice develop normally without an apparent anti-Thy-1.1 nephritis, an experimental mesangioproli-
phenotype except for female infertility. Female mice are ferative GN model in the rat, glomerular Egr-1 expres-
infertile because of LH- deficiency and infertility is sion increased sixfold on day 6 of nephritis, which co-
successfully reversed by LH- substitution. The LH- incides with the maximal mesangioproliferative activity
promotor was shown to bear an Egr-1 consensus se- observed in this model in vivo.
quence and to be responsive to Egr-1 [27, 28]. In the current study we, therefore, wanted to investi-
Under some specific disease situations, a pathologic gate whether inhibition of Egr-1 expression in vivo in a
phenotype of Egr-1–deficient mice becomes apparent. rat model of mesangioproliferative GN interfered with
In a murine model of normobaric hypoxia, pulmonary mesangial cell mitogenesis. For this purpose, specific AS
fibrin deposition is a result of a rapid expression of Egr-1, ODN against Egr-1 were delivered to the mesangial com-
which consecutively leads to transcription and expres- partment using the hemagglutinating virus of Japan
sion of TF in the hypoxic lung. In contrast Egr-1–
(HVJ)/liposome method. This method was successfully
deficient mice subjected to hypoxia displayed neither
used before for specific gene transfer to the glomerulusTF expression nor was intravascular fibrin deposition
and especially to mesangial cells [41–44].detectable [11]. Furthermore, Egr-1 is overexpressed in
a majority of prostate cancers [30–32] and is implicated
in the regulation of several genes important for prostate METHODS
tumor progression. In Egr-1 knockout mice it was dem- Experimental disease
onstrated that Egr-1 deficiency did not prevent tumor
In 4-week-old male Sprague-Dawley rats (150 g;initiation or tumor growth rate; however, Egr-1 defi-
Charles River, Sulzfeld, Germany) experimental GN wasciency significantly delayed the transition from localized
induced by injection of monoclonal antibody (mAb)carcinoma in situ to invasive carcinoma [33].
ER4, directed against the Thy-1.1 antigen (1 mg/kg bodyIn addition to these experiments in Egr-1–deficient
weight; Antibody Solutions, Palo Alto, CA, USA) intomice, several potentially important functions of the tran-
the tail vein [45]. On day 3 of disease, different ODNscription factor Egr-1 have been characterized in various
were transferred using the HVJ/liposome method. Ondisease models. While Egr-1 is expressed at low or unde-
day 4, 6, or 10 of disease, rats were perfused with 100tectable levels in the normal rat artery wall, it is dramati-
mL phosphate-buffered saline (PBS) via the abdominalcally induced following mechanical injury [34, 35]. Smooth
aorta, renal tissue was prepared for histochemistry, andmuscle cell (SMC) proliferation is a key event in blood
glomeruli were isolated by a sequential sieving techniquevessel repair after arterial injury and Santiago et al
(mesh size, 180m, 125m, or 75m) [5] for preparation[36, 37] were able to show that SMC proliferation and
of glomerular protein.regrowth after scraping injury in vitro were both inhib-
ited by antisense oligonucleotides (AS ODN) against
ODN used for the studyEgr-1. More important, the same authors demonstrated
Sequences of phosphothioate-modified antisense (AS),using DNA enzyme technology to inhibit Egr-1 induc-
tion that SMC proliferation could not only be prevented scrambled (SCR), and mismatched (M) ODN (MWG,
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Biotech, Ebersberg, Germany) and their positions rela- rats were anesthetized by intraperitoneal injection of pen-
tobarbital (50 mg/kg body weight). A catheter (Insyte-Wtive to the translational AUG start site:
24GA/0.75IN, Becton Dickinson, Heidelberg, Germany)AS1: 5-GCGGGGTGCAGGGGCACACT-3 (118
was inserted into the left renal artery via the abdominalto –99)
aorta, and the suprarenal aorta was clipped with a ves-SCR1: 5-AGGCTGGCTGCCGGGAGCGA-3
sel clamp (Micro Serrefines 18055-01, Fine ScienceAS2: 5-TTACATGCGGGGTGC-3 (107 to –93)
Tools, Heidelberg, Germany). CaCl2 (final concentra-AS2M4: 5-TCAGATGTGGGGTCC-3
tion, 1 mmol/L) was added to the ODN containing HVJ/Twenty-five percent of ODNs were labeled with fluo-
liposome solution and 500 L of the solution were thenrescein at the 5-end for visualization of a successful
injected into the left renal artery and incubated for 10transfer of ODN in kidney biopsy probes.
minutes under ischemic conditions. After the incubation
HVJ/liposome method for the in vivo transfer of ODN period, the catheter was removed and the punction site
was closed with Superglue and the kidney was reper-Culture of HVJ. Chorioallantoic membranes of chicken
fused. The solution was only transferred into the lefteggs with 10-day-old embryos were vaccinated with 100
kidney, the right kidney was left untreated.L virus concentrate (1:1000 in polypeptone). Vacci-
Kidney biopsies were taken 10 minutes after the kid-nated eggs were incubated at 36C for 3 days. The chorio-
ney was reperfused and the tissue was shock frozen inallantoic fluid containing the virus was harvested and
liquid nitrogen. Animals, in which only the Thy-1.1 ne-centrifuged (1000g, 4C, 10 minutes). To isolate the virus,
phritis was induced by antibody injection and no ODNthe supernatant was centrifuged (27,000g, 4C, 30 min-
transfer was performed (“no oligo” control rats), andutes), the pellet was resolved in balanced salt solution
also control animals (control) without any treatment(BSS) (140 mmol/L NaCl, 5.4 mmol/L KCl, 10 mmol/L
were not subjected to aortic clamp or renal perfusionTris HCl, pH 7.6) and incubated overnight at 4C. This
with carrier and renal ischemia.isolation step was repeated, the pellet was suspended in
Immunohistochemistry. To control for successful trans-BSS, low-speed centrifuged to remove aggregated virus
fer of ODN, 3 m cryostat frozen sections of the renalparticles and resuspended in BSS [46].
biopsy specimen were air dried (10 minutes), fixed inPreparation of lipid mixture. Phosphatidylserine (Sigma-
acetone (10 minutes,20C), washed in PBS, and mountedAldrich, Taufkirchen, Germany), phospatidylcholine
with Moviol (Merck, Darmstadt, Germany). Fluorescein(Avanti Polar Lipids, Inc., Alabaster, AL, USA), and
isothiocyanate (FITC)-labeled ODN were visualized bycholesterol (Sigma-Aldrich) were mixed at a weight ratio
fluorescence microscopy (Leica DMR, Filter L4 BP 450-of 1:4.8:2 in chloroform. The lipid mixture (10 mg) was
490; Leica Microsystems GmbH, Wezlar, Germany).
dried on the wall of a specific glass tube (Ø2 cm, Rettberg To costain for mesangial cells, frozen sections were
GmbH, Go¨tttingen, Germany), with the tip of the tube additionally incubated with mAb anti-Thy-1.1 OX7 (1:100
immersed in a 45C water bath in a rotary evaporator in PBS) (Serotec, Oxford, UK) for 1 hour, reverse tran-
to obtain a uniformly thin lipid layer. scription (RS), washed with PBS, and incubated with a
Preparation of ODN-containing liposomes. ODN (200 secondary Cy3-labeled antimouse IgG Ab (1:200 in PBS;
g) in 200 L BSS were added to the dried lipids into Serotec). FITC-labeled ODN and OX7 staining were
the glass tube. Unilamellar liposomes containing ODN visualized by fluorescence microscopy (Leica DMR, Filter
were obtained by 8 vortexing-incubation cycles (vor- G/R 490/20//575/30).
texing 30 seconds, incubating 30 seconds at 37C) and Determination of glomerular cell number, tuft area, and
by a final sonication step for 4 seconds in a water bath number of mitotic figures. For evaluating glomerular cell
sonicator (Sonorex; Bandelin Electronics, Berlin, Ger- number, tuft area, and number of mitotic figures para-
many). After adding 300 L BSS, the glass tube was formaldehyde (5%) fixed, paraffin-embedded tissue sec-
incubated in a shaking water bath (120 rpm, 30 minutes, tions (2 m, 4 m) were treated with 100% xylol, rehy-
37C). To obtain ODN containing HVJ/liposomes, ultra- drated in 100%, 95%, and 70% ethanol. After washing
violet-inactivated (100 erg/mm2/second) virus particles in PBS, the sections were stained with hematoxylin (3
were added to ODN liposome mixture and incubated seconds), washed in water (10 minutes), then stained
in a shaking water bath (120 rpm, 1 hour, 37C). ODN with eosin (2 seconds), and washed (5 minutes). After
containing HVJ/liposomes were isolated by sucrose gradi- dehydrating in 95%, 100% ethanol, and 100% xylol, the
ent ultracentrifugation (24,000 rpm, 3 hours, 4C). The sections were mounted with Entellan (Merck). Glomeru-
ODN/HVJ/liposomes complexes were observed as broad lar tuft area was determined using Leica DMR micro-
band in a layer between BSS and the 30% sucrose solution. scope (400) with Hyperion image analysis software
The ODN/HVJ/liposomes complexes were stored for a (Dietermann und Heuser Solution GmBH, Greifenstein-
maximum of 24 hours at 4C before transfer to the kidney. Beilstein, Germany). Mitotic figures were counted in 548
The content of one glass tube was used per animal. to 1261 glomeruli of three to five experimental animals
and numbers are given as mitotic figures per 100 glomeruli.Injection of ODN/HVJ/liposome complexes. Nephritic
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Protein extraction, Western blot analysis. Isolated glo- costaining with the mAb OX7, a specific mesangial cell
surface marker, we could demonstrate that the ODNmeruli from rat kidneys were lysed by repeated freeze/
thaw cycles in radioimmunoprecipitation assay (RIPA) were indeed delivered predominantly into mesangial
cells (Fig. 1C). A detectable glomerular ODN transfersolution [50 mmol/L Tris HCl, pH 7.2; 10 mmol/L ethyl-
enediaminetetraacetic acid (EDTA), pH 7.2; 150 mmol/L into the right uninjected kidney did not occur (Fig. 1D).
NaCl; 0.1% sodium dodecyl sulfate (SDS); 1% sodium
Specific AS ODN against Egr-1 inhibits glomerulardecholate; 1% Triton X-100; 1 mmol/L phenylmethylsul-
Egr-1 expression during experimentalfonyl fluoride (PMSF); 2 g/mL leupeptin; and 100
anti-Thy-1.1 nephritismol/L sodium orthovanadate]. After Ultra turrax son-
ication (2  30 seconds, 24,000 rpm) (Ultra turrax T25; A total of 200 g of specific AS ODN against Egr-1
(AS2) or mutated control ODN (AS2M4) were injectedJanke und Kunkel Labortechnik, Staufen, Germany),
the suspension was centrifuged (10,000 rpm, 10 minutes, into the left kidney 3 days after induction of anti-Thy-
1.1 nephritis using the HVJ/liposome method. On day 64C) and protein concentration was determined using
the Pierce Protein assay (Pierce, Rockford, IL, USA) of nephritis, glomerular protein lysates were prepared
and tested for expression of Egr-1 protein by Westernaccording to manufacturer’s instructions.
Protein samples containing 30g total glomerular pro- blot analysis (a representative of three experiments is
shown in Fig. 2). We selected day 6 of the disease fortein were denatured by boiling (5 minutes) and separated
on a 7.5% SDS-polyacrylamide gel (SDS-PAGE) under our tests because mesangial cell proliferation as well as
Egr-1 expression are maximal on this day, as demon-reducing conditions. The gels were electroblotted onto
nitrocellulose (NC) membranes (Amersham Pharmacia strated in our earlier studies [4]. Compared to control
animals, nephritic rats showed a sixfold increase in Egr-1Biotech Europe GmbH, Freiburg, Germany), and the
transfer was controlled by Ponceau-S staining. Mem- protein expression. This expression was significantly re-
duced by 48  3% only in the left kidney of AS2 ODNbranes were blocked in PBS containing 0.5% Tween 20
and 5% nonfat dry milk powder to inhibit unspecific transferred rats, whereas the glomerular Egr-1 expres-
sion in the right uninjected kidney of AS2 ODN trans-binding (1 hour, RT). The membranes were incubated
with the primary anti-Egr-1 Ab (1:1000 in PBS/Tween; ferred rats was only minimally reduced (13  1%).
After transfer of mutated control ODN (AS2M4), Egr-1Egr-1 C19, Santa Cruz Biotechnology, Santa Cruz, CA,
USA; 1 hour, RT). Egr-1 was visualized with a secondary expression remained nearly unaffected, both in the in-
jected left as well as in the uninjected right kidney.horseradish peroxidase–conjugated antirabbit IgG Ab
(1:15000 in PBS/Tween; Pierce) using ECL Pierce Super Similar results were obtained when a different AS
ODN (AS1) was used and Egr-1 expression was analyzedSignal Kit system (Pierce). Egr-1 expression was quanti-
fied by scanning densitometry. To stain for PDGF-B by immunoprecipitation and Western blot (data not
shown). We were, therefore, able to specifically inhibitblots were incubated with anti-PDGF-B Ab (1:1000 in
PBS/Tween; PDGF-B H55, Santa Cruz Biotechnology; glomerular Egr-1 protein induction in the left kidney of
nephritic animals by using an HVJ/liposome–mediated1 hour, RT).
transfer of AS ODN against Egr-1.
Statistical analysis
Specific AS ODN against Egr-1 prevents glomerularStatistical analysis was performed using Student t test
hypercellularity and tuft enlargement infor unpaired samples.
anti-Thy-1.1 nephritis
In Figure 3, the histologic changes induced by anti-
RESULTS
Thy-1.1 nephritis and their partial reversion by injection
HVJ/liposome method mediates specific transfer of of AS ODN against Egr-1 into the left kidney are shown.
ODN into glomerular mesangial cells As compared to control kidney (Fig. 3A), a massive
extension in glomerular tuft area, as well as an increaseOn day 3 after induction of anti-Thy-1.1 nephritis,
FITC-labeled AS ODN against Egr-1 incorporated into in glomerular cell number, is seen on day 6 of anti-Thy-
1.1 nephritis (Fig. 3B). These morphologic alterationsHVJ/liposomes were injected into the left renal artery
and incubated for 10 minutes under ischemic conditions. were partially reversed only in the left injected kidney
(Fig. 3C) of specific AS ODN–transferred rats, but notAfter 10 minutes of reperfusion, a kidney biopsy was
taken and snap-frozen in liquid nitrogen. Only those in the right uninjected kidney (Fig. 3D). Transfer of
control ODN had no visible effect on glomerular histol-animals were used for further investigation, in which
cryostat sections revealed a successful transfer of FITC- ogy (data not shown).
To further validate these observations, the number oflabeled AS ODN to nearly all glomeruli of the left in-
jected kidney (Fig. 1A). Transfer was observed mainly nuclei per glomerular cross-section was counted in 50
glomeruli of control rats (N 	 3), of day 6 nephritic ratsto nuclei of cells in mesangial position (Fig. 1B). By
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Fig. 1. Hemagglutinating virus of Japan (HVJ)/liposome-method mediates targeted transfer of fluorescein isothiocyanate (FITC)-labeled oligonu-
cleotides (ODN) into glomerular mesangial cells of the left kidney. Three days after induction of anti-Thy-1.1 nephritis, FITC-labeled antisense
(AS) ODN against Egr-1 incorporated into HVJ/liposomes were injected into the left renal artery and incubated for 10 minutes under ischemic
conditions before reperfusion of the kidney was allowed. After 10 minutes of reperfusion, a kidney biopsy was taken from the lower pole and
snap-frozen in liquid nitrogen. Successful transfer of ODN was visualized by fluorescence microscopy of 3 m cryostat sections. (A) and (B)
Transfer of FITC-labeled ODN into glomeruli of the left kidney (400; 1000). (C) Costaining with anti-Thy-1.1 antibody (Ab) OX7 demonstrates
specific transfer to nuclei of glomerular mesangial cells (400). (D) No specific staining is observed in the right uninjected kidney (400).
(N 	 3), in the left and right kidney each of AS1 (N 	 where a 39% reduction of the increase in cell number
per glomerular cross-section was noted (data not shown).5) or AS2 (N 	 3) ODN–injected nephritic rats and in
the left and right kidney each of SCR1 (N	 4) or AS2M4 Comparable results were obtained when we measured
the glomerular tuft area (Fig. 5). The increase in glomer-(N 	 4) control ODN–injected nephritic animals.
The increase in glomerular cell number on day 6 of ular tuft area seen in day 6 nephritic animals was signifi-
cantly diminished by about 50% only in the left kidneynephritis was significantly inhibited in the left kidney by
transfer of specific AS ODN (AS1, AS2) against Egr-1 of AS ODN (AS1/AS2)–transferred rats. Tuft area en-
largement in the right uninjected kidney of AS ODN–by 54% and 65%, respectively (Fig. 4).
Neither transfer of scrambled (SCR1) nor mutated transferred rats or in control ODN-treated rats was not
significantly altered.(AS2M4) control ODN influenced glomerular cell num-
ber. A slight, albeit not significant, suppression of the
Specific transfer of AS ODN against Egr-1 reducesincrease in glomerular cell number was observed in the
the number of mitotic figures in anti-Thy-1.1 nephritisright uninjected kidney of AS ODN–transferred rats.
This is in accordance with the consistently observed To further substantiate our data, the number of glo-
merular mitotic figures was counted in healthy controlslight reduction in glomerular Egr-1 protein expression
in the right kidney of AS ODN–injected nephritic ani- animals, in nephritic animals, and in ODN-injected ani-
mals (Fig. 6). The number of mitotic figures per 100mals (see Fig. 2). The antiproliferative effect of AS ODN
against Egr-1 was still observed on day 10 of nephritis, glomeruli increased from 2/100 in control animals to 13/
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Fig. 2. Inhibition of glomerular Egr-1 expres-
sion by specific antisense oligonucleotides (AS
ODN) against Egr-1 during experimental anti-
Thy-1.1 nephritis. Three days after induction
of mesangioproliferative anti-Thy-1.1 nephri-
tis, AS ODN against Egr-1 (AS2) or mutated
control ODN (AS2M4) were transferred into
the left kidney by the hemagglutinating virus
of Japan (HVJ)/liposome method. On day 6
of nephritis, animals were sacrificed, kidneys
were removed, and glomeruli were isolated by
the differential sieving technique. Glomerular
protein lysate (30 g) was separated by sodium
docedyl sulfate-polyacrylamide gel phoresis
(SDS-PAGE) and blotted onto NC mem-
branes. Egr-1 protein was detected by a poly-
clonal Egr-1 antibody (Ab) and a secondary
horseradish peroxidase–conjugated antirabbit
immunoglobulin (IgG) Ab using the Pierce
Super Signal Detection system. Specific inhibi-
tion of glomerular Egr-1 protein expression is
only observed in the left kidney (AS2 left) of
AS ODN–injected animals, not in the right
kidney (AS2 right) or in the kidneys of control
ODN–injected animals (AS2M4 left; AS2M4
right). (A) Western Blot analysis showing a
representative of three independent experi-
ments. (B) Densitometric analysis of three in-
dependent experiments. Glomerular Egr-1
protein expression in Thy-Thy-1.1 animals not
treated with ODN is set at 100%; average 
SD of three experiments is shown. *P 
 0.05
100 on day 4 and to 17/100 on day 6 of anti-Thy-1.1 mately 16-fold from control animals to day 6 nephritic
animals. We, therefore, investigated the glomerular ex-nephritis. Both on day 4 and on day 6 of anti-Thy-1.1
nephritis, transfer of specific AS ODN against Egr-1 pression of PDGF-B, after transfer of AS ODN against
Egr-1 (Fig. 7). Corresponding to the inhibition of Egr-1(AS2) considerably inhibited the number of mitotic fig-
ures in the left kidney (46% on day 4, 53% on day expression, seen in Figure 2, transfer of AS ODN against
Egr-1 (AS2) by the HVJ/liposome method repressed6). Again, no significant changes were seen in the right
kidney of AS ODN–injected animals or in the kidneys the glomerular PDGF-B protein expression in the left
of control ODN (AS2M4)–injected animals. kidney by 55%, whereas the glomerular PDGF-B expres-
As already shown in our previous studies, AS ODN sion in the right uninjected kidney of AS2 injected rats
against Egr-1 also inhibits proliferation of cultured rat and in mutated control ODN (AS2M4)–injected rats was
mesangial cells [3]. Quiescent mesangial cells were incu- not influenced.
bated with specific AS ODN for 16 hours before stimulat-
ing with 4% fetal calf serum (FCS). AS ODN with pro-
DISCUSSIONnounced effects on Egr-1 protein expression (AS1,55%;
Glomerular hypercellularity is one of the histopatho-AS2,47%) proved to be potent inhibitors of mesangial
logic hallmarks of GN and can lead, if not successfullycell growth (AS1, 46%; AS2, 38%). In contrast, an
reversed by repair processes, to progressive glomerularAS ODN against Egr-1 (AS3) that was ineffective in
extracellular matrix deposition and sclerosis and ulti-blocking Egr-1 induction failed to suppress mesangial
mately to loss of renal function and end-stage renal dis-cell growth and mutated, and scrambled control ODN
ease.had no effect on mesangial cell proliferation in culture
In our previous work, we could demonstrate a strong[3] (data not shown).
up-regulation of the transcription factor Egr-1 in an in
Glomerular transfer of specific AS ODN against Egr-1 vivo model of mesangioproliferative GN, the anti-Thy-
inhibits glomerular expression of the 1.1 model in the rat. Our studies also revealed a direct
Egr-1 target PDGF-B correlation between Egr-1 up-regulation and mesangial
cell proliferation, since maximal Egr-1 expression thatIn its function as a transcriptional activator Egr-1 regu-
was observed on day 6 of the disease coincided with thelates the induction of specific target genes. One of the
strongest proliferative activity in this model. The role ofEgr-1 target genes also linked to mesangial cell prolifera-
tion is PDGF-B. PDGF-B expression increased approxi- Egr-1 for mesangial cell proliferation was further sub-
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Fig. 3. Morphologic changes induced by anti-Thy-1.1 nephritis can be partially reversed by hemagglutinating virus of Japan (HVJ)/liposome-
mediated transfer of specific antisense oligonucleotides (AS ODN) against Egr-1. Anti-Thy-1.1 nephritis was induced by injection of monoclonal
antibody (mAb) ER4. On day 3 of nephritis, AS2 ODN containing HVJ/liposomes were injected into the left kidney and kidneys were removed
on day 6 of nephritis. Hematoxylin & eosin–stained 2 m sections of kidneys from healthy control rats (A), day 6 nephritic rats (B), and the left
(C) and right (D) kidney of AS2 ODN–injected day 6 nephritic rats are shown (400).
stantiated by our in vitro observations, where inhibition ferred specific AS ODN against Egr-1 into the mesangial
compartment on day 3 of the disease by the HVJ/lipo-of Egr-1 expression by specific AS ODN prevented mito-
gen-induced mesangial cell proliferation [3]. In these some gene transfer method. The HVJ/liposome method
was successfully applied in the past to demonstrate thestudies, in cultured mesangial cells, we identified specific
AS ODN that selectively inhibited Egr-1 protein expres- role of PDGF and TGF- in glomerular disease [42, 47].
The HVJ/liposome method allows a targeted transfersion, whereas the expression of c-fos or c-jun, two other
members of the immediate early gene transcription fac- of DNA into glomeruli and selectively into nuclei of
mesangial cells, as shown by double immunofluorescencetor family, was unaffected [3, 4]. Several AS ODNs were
used and the inhibitory action of AS ODN on mesangial studies staining for the mesangial cell Thy-1.1 surface
antigen with the OX7 Ab and using FITC-labeled ODN.cell proliferation directly correlated with their ability to
inhibit Egr-1 protein expression. AS ODN that had no In successfully transferred animals, 90% to 95% of glo-
meruli exhibited a strong nuclear fluorescent staining.effect on Egr-1 protein did not influence mesangial cell
proliferation. Sense, scrambled, and especially mutated Only rats that showed a successful transfer of ODN in
biopsy probes were used for further tests (approximately(switch of 4 base pairs) control ODN were designed and
proved to be without effect on Egr-1 protein expression 50% of all investigated animals). On a given glomerular
cross-section, an estimated 60% of mesangial cells couldor mesangial cell proliferation [3].
The aim of the present study was to establish a causal be targeted. Since we did not investigate different stages
during the mesangial cell cycle, it is not known whetherrelationship between Egr-1 induction and mesangial cell
proliferation in vivo. For this purpose we chose the mes- predominantly proliferating or rather quiescent mesan-
gial cells incorporated the transferred ODN. We couldangioproliferative anti-Thy-1.1 GN model and trans-
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Fig. 4. Transfer of specific antisense oligonucleotides (AS ODN) against Egr-1 significantly inhibits the increase in glomerular cell number on
day 6 of anti-Thy-1.1 nephritis. Three days after induction of anti-Thy-1.1 nephritis AS ODN (AS1 and AS2) or control ODN (SCR1 and AS2M4)
containing hemagglutinating virus of Japan (HVJ)/liposomes were injected into the left kidney. On day 6 of nephritis, kidneys were removed and
the number of nuclei per glomerular cross-section was evaluated on 2 m sections of 5% paraformaldehyde (PFA)-fixed paraffin-embedded tissue.
Two separate experiments were performed with transfer of ODN AS2 and AS2M4 in (A) and AS1 and SCR1 in (B). The increase in the number
of nuclei per glomerular cross-section (GCS) over control is shown. The average number of nuclei/GCS in control animals was 47 (A) and 53 (B),
respectively. *P 
 0.05; **P 
 0.01; ***P 
 0.001.
show, however, that healthy untreated control rats with- though we never detected any fluorescent activity in glo-
meruli of the right kidney.out detectable mesangial cell proliferation could be ef-
fectively transferred, demonstrating that resting mesan- The ODN selected for our studies are described in
detail in our previous work [3]. The effectivity of ODNgial cells can be effectively targeted.
In Western blot analyses of glomerular protein we depends on sequence-specific target sites within the
mRNA; however, no general guidelines for AS ODNfound that Egr-1 protein expression was reduced by 48%
in the left kidney of AS1 ODN–transferred animals. selection exist. AS1 and AS2 ODN recognize sequences
slightly upstream of the AUG start codon and were theSince not all mesangial cells can be successfully targeted,
a higher extent of inhibition was not expected. According most effective inhibitors of Egr-1 induction and mesan-
gial cell proliferation in vitro [3, 4] and were thereforeto the extent of Egr-1 protein inhibition, AS ODN against
Egr-1 led to a significant, albeit not complete, inhibition used for the in vivo studies. To exclude unspecific effects
of ODN, we used two different AS ODNs and variousof mesangial cell proliferation. Mesangial cell prolifera-
tive activity was determined by counting number of mi- control ODN. The two AS ODN, AS1 and AS2, were
capable of inhibiting mesangial cell proliferation and alltotic figures, or of nuclei per glomerular cross-section.
In most of our experiments, we observed a minimal, control ODN were without significant effect. We selected
scrambled and mutated control ODN since they havealthough not significant, inhibitory effect on Egr-1 induc-
tion and mesangial cell proliferation in the right unin- exactly the same relative content of the various nucleo-
tides as the corresponding AS ODN. In the mutatedjected kidney. We think that this effect is caused by
systemic delivery of AS ODN after reperfusion, even ODN, the T in position 2 was exchanged with the C in
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procedure, including the short ischemia and reperfusion,
did not affect glomerular structure.
We did not measure characteristic clinical parameters
of glomerular disease activity like proteinuria or hematu-
ria, since only the left kidney was treated with AS ODN
against Egr-1 and the right kidney would still significantly
contribute to these markers. It would, however, be very
interesting to perform experiments on uninephrectom-
ized nephritic rats in the future and to monitor protein-
uria, hematuria, and renal function under these settings.
Our observations, that Egr-1 is critically linked to the
mesangial proliferative response not only in the in vitro
but also in the in vivo situation of glomerular inflamma-
tion, add to the growing list of recently reported biologic
functions of the Egr-1 protein and further corroborates
its role in proliferative processes. Since mesangial cells
share many properties of SMC, our data fit very well in
line with observations by Santiago et al [36–38], who
Fig. 5. Transfer of specific antisense oligonucleotides (AS ODN) were able to show that SMC proliferation and regrowth
against Egr-1 significantly prevents enlargement of glomerular tuft area. after scraping injury in vitro, but also after balloon injuryThree days after induction of anti-Thy-1.1 nephritis, AS ODN (AS1 and
AS2) or control ODN (SCR1 and AS2M4) containing hemagglutinating in the rat carotid artery model in vivo, are critically
virus of Japan (HVJ)/liposomes were injected into the left kidney. On dependent on the induction of Egr-1. With the exception
day 6 of nephritis, kidneys were removed and tuft area per glomerular
of female infertility, Egr-1–deficient mice develop nor-cross-section was evaluated on 2 m sections of 5% paraformaldehyde
(PFA)-fixed paraffin-embedded tissue. Increases in glomerular tuft area mally, and no apparent phenotype related to disordered
over control are given. Average glomerular tuft area in control animals
growth control becomes evident [27, 28]. Nevertheless,was 3896 m2. *P 
 0.05; **P 
 0.01; ***P 
 0.001.
it will be interesting to see how the course of various GN
models is altered in Egr-1–deficient mice and whether,
indeed, a reduced proliferative response can be observed
position 8 and the C in position 4 was exchanged with under disease conditions.
the G in position 14, therefore, even the sequence of The exact role of Egr-1 in the mitogenic signal trans-
nucleotides is maintained in large parts when compared duction cascade is not entirely understood. In its function
to the corresponding AS ODN. We demonstrated that as a transcriptional activator, Egr-1 induces the transcrip-
the AS ODN used were also effective inhibitors of serum- tion of several target genes some of which, like the
induced Egr-1 induction and mesangial cell proliferation PDGF-A chain [17, 18], the PDGF-B chain [34], FGF-2
in cultured rat mesangial cells. Another AS ODN, AS3 [20] or cyclin D [25], have been linked to proliferative
was not able to attenuate the increase in Egr-1 protein
processes. PDGF-B is strongly up-regulated during ex-
after serum stimulation and was also ineffective in
perimental mesangioproliferative GN and it was demon-
blocking mesangial cell proliferation in vitro, further un-
strated by several techniques, including neutralizing anti-derlining the specific effects of AS1 and AS2 ODN [3].
body infusion [48] or application of aptamers [49], thatIn addition to the reduction in cell number per glomer-
PDGF exerts a critical role in inducing mesangial cellular cross-section by transfer of specific AS ODN against
proliferation. We, therefore, tested whether the Egr-1Egr-1 into nephritic kidneys, the enlargement of the glo-
target gene PDGF-B was suppressed in anti-Thy-1.1-merular tuft size observed in nephritic animals was sig-
nephritis after transfer of AS ODN against Egr-1. Anificantly reduced in the AS ODN injected left kidney.
clear down-regulation of PDGF-B protein was observedGlomerular tuft size was not significantly altered in the
in nephritic glomeruli transferred with AS ODN againstright kidney of AS ODN–injected animals or in the kid-
Egr-1 as compared with nontransferred nephritic glo-neys of control ODN–injected animals. Since we do not
meruli. We cannot, however, finally prove that reducedobserve any significant differences in Egr-1 expression,
PDGF-B expression is a direct consequence of reducedglomerular cell number, number of mitoses, or glomeru-
Egr-1 protein availability or whether reduced PDGF-Blar tuft size between kidneys of nephritic animals not
expression is due to deactivation and reduced numbertreated with ODN, and both kidneys of control ODN–
of mesangial cells, which are the main source of PDGF-Btreated animals (left kidney injected and subjected to
ischemia), we conclude that the HVJ/liposome transfer in this model.
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Fig. 6. Transfer of specific antisense oligonucleotides (AS ODN) against Egr-1 reduces the number of mitotic figures in glomeruli of nephritic
rats. Three days after induction of anti-Thy-1.1 nephritis AS ODN (AS2) or mutated control ODN (AS2M4) containing hemagglutinating virus
of Japan (HVJ)/liposomes were injected into the left kidney. Kidneys were removed on day 4 and day 6 of nephritis and the number of mitotic
figures per 100 glomeruli was counted on 2 m sections of 5% paraformaldehyde (PFA)-fixed paraffin-embedded kidneys. (A) A mitotic figure
(anaphase) is shown in a hypercellular area of the glomerular tuft (circled area). (B) Number of mitotic figures per 100 glomeruli on day 4 and
day 6 of anti-Thy-1.1 nephritis is given. The number of glomeruli counted in three to five animals per experimental condition is indicated.
gial cell proliferation can be achieved not only in vitro
but also in vivo in experimental mesangioproliferative
GN. The identification of additional, potentially kidney-
specific target genes of Egr-1 should add to our under-
standing of proliferative glomerular processes. Targeting
Egr-1 at the mRNA or protein level or interfering with
the expression of its target genes could open new avenues
for therapeutic interventions.
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